1878P Health-related quality of life (HRQoL) assessment for patients with advanced renal cell carcinoma (aRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient reported outcomes in daily clinical practice: QUANARIE trial
Keyword(s):
2016 ◽
Vol 58
(7)
◽
pp. 1598-1606
◽
Keyword(s):
2014 ◽
Vol 24
(4)
◽
pp. 919-926
◽
Keyword(s):